After Bausch + Lomb (BLCO) announced a voluntary recall of its enVista intraocular lenses, RBC Capital says talks with management indicated ...

RBC Capital analyst Gregory Pardy maintained a Buy rating on Canadian Natural (CNQ – Research Report) today and set a price target of C$63.00.

Royal Bank of Canada will look to expand its foothold in capital markets and wealth management globally, CEO Dave McKay said ...

RBC Wealth Management, North America’s best private bank for high-net-worth (HNW) customers, is a clear industry leader in ...

(Reuters) - Royal Bank of Canada CEO Dave McKay on Thursday underscored the role of artificial intelligence in fueling the ...

RBC Wealth Management's unique expertise, innovative solutions and client-centric approach make it the leader in private ...

UBS Group AG has hired three investment bankers specializing in biotechnology from RBC Capital Markets as the bank looks to expand its health-care dealmaking in the US.Noël Brown will become head of ...

TORONTO (Reuters) -When Royal Bank of Canada convenes its first investor day in seven years on Thursday, shareholders will ...

On Monday, RBC Capital Markets adjusted its stance on Liberty Energy Inc (NYSE:LBRT), downgrading the stock from Outperform to Sector Perform and revising the price target downward to $19 from the ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Investors anticipate strategic shift towards Europe, higher-margin businesses US accounts for 26% of RBC's revenue Since RBC's last investor day in June 2018, its stock has gained 66% TORONTO ...